OMB control number
Expedited Programs for Serious Conditions-Drugs and Biologics
OMB 0910-0765 · HHS/FDA.
OMB 0910-0765
This ICR collects information from sponsors and applicants who wish to obtain a priority review designation or breakthrough therapy designation. Respondents to the collection are manufacturers or sponsors of drug and/or biologic products.
The latest form for Expedited Programs for Serious Conditions-Drugs and Biologics expires 2028-03-31 and is listed under ICR 202408-0910-006.
Latest Forms, Documents, and Supporting Material
All Historical Document Collections
| Reference | Filing | Received | Concluded | Action |
|---|---|---|---|---|
| 202408-0910-006 | Revision of a currently approved collection | 2024-08-23 | ||
| 202407-0910-004 | Extension without change of a currently approved collection | 2024-07-22 | Withdrawn and continue | |
| 202309-0910-011 | Revision of a currently approved collection | 2024-04-18 | Withdrawn and continue | |
| 202102-0910-008 | Extension without change of a currently approved collection | 2021-03-26 | Approved without change | |
| 201809-0910-004 | No material or nonsubstantive change to a currently approved collection | 2018-09-25 | Approved without change | |
| 201802-0910-008 | Revision of a currently approved collection | 2018-02-13 | Approved without change | |
| 201703-0910-010 | Extension without change of a currently approved collection | 2017-03-15 | Approved without change | |
| 201312-0910-015 | New collection (Request for a new OMB Control Number) | 2013-12-31 | Approved without change |
OMB Details
Priority Review Designation Requests (Expedited Programs for Serious Conditions) - CDER
Federal Enterprise Architecture: Health - Consumer Health and Safety